Navigation Links
Nektar Therapeutics Reports Fourth Quarter and Year-End 2012 Financial Results
Date:2/28/2013

lude Baxter's BAX 855, a long-acting PEGylated rFVIII program, which is in Phase 3 clinical development.

Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India.  Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

Cautionary Note Regarding Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "expect," "believe," "should," "may," "will" and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding the potential future regulatory filings by AstraZeneca for naloxegol; the projected timing of the start of the Phase 3 clinical study by Bayer for Amikacin Inhale; the projected availability of Phase 2 clinical study results for NKTR-181; and the value and potential of our technology and research and development pipeline. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results to differ materially from th
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Nektar To Host Conference Call To Discuss The Positive Phase 3 Clinical Results For Naloxegol
2. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
3. Nektar to Announce Financial Results for the Third Quarter of 2012 On Tuesday, November 13, 2012, After Close of U.S.-Based Financial Markets
4. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the UBS 2012 Global Life Sciences Conference in New York City
5. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
6. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
7. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
8. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
9. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
10. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
11. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... -- Smile Train and its technology partner BioDigital have been ... among leading global health innovations in The Hive at ... Washington, D.C. at The John F. Kennedy ... Train is honored to be represented through our partnership ... health and medicine that TEDMED unites each year," said ...
(Date:7/25/2014)... -- CVS Caremark Corporation (NYSE: CVS ) will ... 2014, at 8:30 a.m. (EDT) with analysts and investors ... An audio webcast of the conference call will ... the CVS Caremark website for all interested parties.  To ... will be archived and available on the web site ...
(Date:7/25/2014)... Cardinal Health will today name three of the nation,s ... Independent Pharmacy Best Practices Competition, during the company,s ... gatherings of independent pharmacists. The Best ... Ohio , Tennessee and ... implementing exceptionally creative methods that demonstrate how independent pharmacies ...
Breaking Medicine Technology:Smile Train and BioDigital Selected to Showcase Virtual Surgery Simulator in The Hive at TEDMED 2014 2Smile Train and BioDigital Selected to Showcase Virtual Surgery Simulator in The Hive at TEDMED 2014 3Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 2Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 3Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 4Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 5Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 6
... 1, 2012  Ultragenyx Pharmaceutical Inc., a biotechnology company ... genetic disorders, today announced results from a first-in-human, ... with hereditary inclusion body myopathy (HIBM) showing that ... profile on absorption after oral administration.  UX001 is ...
... (OTC Bulletin Board: NWBO ) (NW Bio) today announced ... received approval of a major grant from the Sachsische Aufbau ... will reimburse fifty percent (50%) of the costs for manufacturing ... for brain cancer at up to ...
Cached Medicine Technology:Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease 2Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease 3Northwest Bio Awarded $5.5 Million German Government Grant 2Northwest Bio Awarded $5.5 Million German Government Grant 3Northwest Bio Awarded $5.5 Million German Government Grant 4
(Date:7/26/2014)... July 26, 2014 Studio B Dental in ... implant, often called Teeth in a Day, gives patients the ... full set of bright, pearly whites with very little recovery ... permanent, look and feel just like natural teeth, and require ... checkups. Studio B Dental is one of the premiere ...
(Date:7/26/2014)... 26, 2014 According to the Metabolic ... is a comprehensive bodybuilding program that helps men lose ... anabolic steroids . The program also instructs men how ... , Vkool reveals in its review that this ... can help men get ripped and jacked at the ...
(Date:7/26/2014)... 26, 2014 The birth control safety ... IUD contraceptive of new legal information on the site. ... the number of lawsuits pending for July alleging side ... resource for those using popular prescription drugs and medical ... studies and legal news all in one place, they ...
(Date:7/25/2014)... 2014 Deep Research Report on ... Industry” is a professional and in-depth research report ... market. The report provides basic Laser Scanning Confocal ... definition, classification, application, and industry chain structure ... international market analysis, including China’s domestic market as ...
(Date:7/25/2014)... 2014 A federal judge has denied ... DePuy Pinnacle hip lawsuits ( http://www.depuypinnacle-lawsuit.com/ ) selected ... to go before a jury on September 1, 2014, ... July 18th, U.S. District Judge Ed Kinkeade of the ... claims may proceed to trial against Johnson & Johnson, ...
Breaking Medicine News(10 mins):Health News:Studio B Dental Improves Patient Smiles with All-on-Four Dental Implants 2Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 2Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 3Health News:DrugNews Adds Latest Court Updates on Mirena IUD Lawsuits 2Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 2Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 3Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 4Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 2Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 3Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 4
... demonstrating why the cold pressed oil of Siberian Cedar ... an ancient super food. In a clinical trial conducted ... Hospital of Novosibirsk # 1 with wild harvested, cold ... results were found. Pine nut oil was proven effective ...
... and operator of two Miami medical clinics has pleaded ... a $5.3 million HIV infusion fraud scheme, Acting Assistant ... U.S. Attorney R. Alexander Acosta of the Southern District ... on Jan. 7, 2009, to conspiracy to commit healthcare ...
... debilitating, isolating and can lead to severe depression yet ... regarded as ,normal, in later life. Now a new study ... pain and how best Government, the NHS and social care ... in older people: reflections and experiences from an older person,s ...
... -Kid-Friendly, Nutritionally Complete Drink with First-Ever Immune- , ... 8 Today, parents have a new way ... protective benefits with the launch of BOOST(R) Kid ... innovative product developed by Nestle HealthCare Nutrition--is the ...
... included nearly 57,000 women who had been followed for ... -- Hormone therapy may lower a woman,s risk of ... the hormones. , This new finding, published in the ... , further complicates an already murky picture of the ...
... Poniard,Pharmaceuticals, Inc. (Nasdaq: PARD ), ... today provided an overview of its 2009 ... product candidate. Picoplatin is,a new generation platinum-based ... platform product addressing multiple indications, combinations and,formulations. ...
Cached Medicine News:Health News:RingingCedarsofRussia.org Releases Pine Nut Oil Research Showing That Digestive and Stomach Disorders Respond to Unique Super Food: Siberian Pine Nut Oil 2Health News:Medical Clinic Owner Pleads Guilty to Role in $5.3 Million Medicare Fraud Scheme 2Health News:A life with pain -- new study examines the experiences of older people 2Health News:A life with pain -- new study examines the experiences of older people 3Health News:A life with pain -- new study examines the experiences of older people 4Health News:Nestle Nutrition Launches BOOST(R) Kid Essentials Nutritionally Complete Drink 2Health News:Nestle Nutrition Launches BOOST(R) Kid Essentials Nutritionally Complete Drink 3Health News:Hormone Therapy May Cut Colorectal Cancer Risk 2Health News:Poniard Pharmaceuticals Provides 2009 Clinical Data Goals for Picoplatin 2Health News:Poniard Pharmaceuticals Provides 2009 Clinical Data Goals for Picoplatin 3Health News:Poniard Pharmaceuticals Provides 2009 Clinical Data Goals for Picoplatin 4Health News:Poniard Pharmaceuticals Provides 2009 Clinical Data Goals for Picoplatin 5
PS2A200 Power supply is a high current power supply ideal for all types of electrophoresis blotting and short electrophoresis runs....
EPS 3501 : 3500 V, 150 mA, 100 W maximum. Constant voltage, constant current, or constant power modes. Stores and recalls three protocols. Excellent for manual DNA sequencing and IEF applications....
... C.B.S.SCIENTIFIC offers four different Series II ... the EPS-4000-II, and the EPS-6000-II. These ... constant current, and constant power operating ... powerful 300 milliamps maximum current/300 watts ...
... The PowerPac Basic power supply, ... output of 10-300 V, 4-400 ... unit contains a built-in switch ... with the appropriate power cord. ...
Medicine Products: